FBXO5 and breast cancer: In this study, we proved that METTL16 increases the mRNA stability of FBXO5 through m6A modification and promotes the malignant behavior of BC, revealing the role and regulatory mechanism of METTL16 in BC and providing new potential target for the diagnosis and cure of BC.